Abstract
Background: Recent studies show that together with serotonin (5-hydroxytryptamine; 5-HT), leptin also plays an important role in the etiology of depression. Tryptophan increases brain 5-HT but the effects of tryptophan on leptin and responses to stress are not known.
Objective: To evaluate the effect of tryptophan load (300mg/kg, orally) on serotonin metabolism, circulating levels of leptin and behavioral responses to single (2hr) and repeated (2hr/day for 6 days) immobilization stress in rats. Method: Albino-wistar rats were randomly assigned to two groups (n = 24) for single and repeated immobilization with further division in four equal groups; water/tryptophan treated unstressed and stressed groups. Behavioral studies and biochemical estimation were performed. Results: Acute exposure to 2hr immobilization decreased food intake, body weight and elicited anxiety like behavior. It increased circulating leptin and brain 5-HT metabolism. The stress-induced behavioral deficits and increases of leptin did not occur following repeated immobilization while the levels of brain 5-HT decreased. Immobilization-induced behavioral deficits were smaller in tryptophan than water treated animals. Tryptophan administration also increased serum leptin levels but inhibited stress-induced increases of leptin. Repeated administration of tryptophan did not increase leptin; tryptophan treated animals exposed to repeated immobilization exhibited smaller leptin levels. Conclusion: Tryptophan induced increases of brain 5-HT reduces stress effects on hormones and behavior but have little effects in unstressed animals suggesting, these increases are available at functional sites only in stressful conditions. While, in control animals these increases occur only intra-neuronally.Keywords: Tryptophan, serotonin, leptin, adaptation to stress, elevated plus maze, light-dark transition.
Graphical Abstract
Current Psychopharmacology
Title:Serotonergic and Behavioral Responses to Stress with Tryptophan in Rats
Volume: 6
Author(s): Sumera Gul*, Darakhshan J. Haleem, Sabira Naqvi, Shazia Nawaz, Tabinda Salman, Qurrat-ul-aen Inam and Ahsana Dar
Affiliation:
- Neuroscience Research Laboratory, Dr. Panjwani Center for Molecular Medicine and Drug Research, University of Karachi, Karachi 75270,Pakistan
Keywords: Tryptophan, serotonin, leptin, adaptation to stress, elevated plus maze, light-dark transition.
Abstract: Background: Recent studies show that together with serotonin (5-hydroxytryptamine; 5-HT), leptin also plays an important role in the etiology of depression. Tryptophan increases brain 5-HT but the effects of tryptophan on leptin and responses to stress are not known.
Objective: To evaluate the effect of tryptophan load (300mg/kg, orally) on serotonin metabolism, circulating levels of leptin and behavioral responses to single (2hr) and repeated (2hr/day for 6 days) immobilization stress in rats. Method: Albino-wistar rats were randomly assigned to two groups (n = 24) for single and repeated immobilization with further division in four equal groups; water/tryptophan treated unstressed and stressed groups. Behavioral studies and biochemical estimation were performed. Results: Acute exposure to 2hr immobilization decreased food intake, body weight and elicited anxiety like behavior. It increased circulating leptin and brain 5-HT metabolism. The stress-induced behavioral deficits and increases of leptin did not occur following repeated immobilization while the levels of brain 5-HT decreased. Immobilization-induced behavioral deficits were smaller in tryptophan than water treated animals. Tryptophan administration also increased serum leptin levels but inhibited stress-induced increases of leptin. Repeated administration of tryptophan did not increase leptin; tryptophan treated animals exposed to repeated immobilization exhibited smaller leptin levels. Conclusion: Tryptophan induced increases of brain 5-HT reduces stress effects on hormones and behavior but have little effects in unstressed animals suggesting, these increases are available at functional sites only in stressful conditions. While, in control animals these increases occur only intra-neuronally.Export Options
About this article
Cite this article as:
Gul Sumera*, Haleem J. Darakhshan, Naqvi Sabira, Nawaz Shazia, Salman Tabinda, Inam Qurrat-ul-aen and Dar Ahsana, Serotonergic and Behavioral Responses to Stress with Tryptophan in Rats, Current Psychopharmacology 2017; 6 (1) . https://dx.doi.org/10.2174/2211556006666170130123741
DOI https://dx.doi.org/10.2174/2211556006666170130123741 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease
CNS & Neurological Disorders - Drug Targets The Use of Chronobiotics in the Resynchronization of the Sleep/Wake Cycle. Therapeutical Application in the Early Phases of Alzheimer's Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) A Review of Methods and Tools for Database Integration in Biomedicine
Current Bioinformatics Endogenous Facilitation: From Molecular Mechanisms to Persistent Pain
Current Neurovascular Research Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data)
Current Cancer Drug Targets Recent Advances in Epilepsy
Current Neuropharmacology Macrocyclic Lactones for Parasite Control in Equids
Current Pharmaceutical Biotechnology In Vitro Antioxidant Activity of Some Novel Synthetic Mononuclear Ruthenium (II) Compounds
Letters in Drug Design & Discovery STIP Regulates ERK1/2 Signaling Pathway Involved in Interaction with PP1γ in Lymphoblastic Leukemia
Current Molecular Medicine The GH/IGF-1 Axis in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Blockade of Renin Angiotensin System in Heart Failure Post-Myocardial Infarction: What is the Best Therapy?
Recent Patents on Cardiovascular Drug Discovery Neurogenesis and Sensorimotor Gating: Bridging a Microphenotype and an Endophenotype
Current Molecular Medicine Fish Oil has Beneficial Effects on Behavior Impairment and Oxidative Stress in Rats Subjected to a Hepatic Encephalopathy Model
CNS & Neurological Disorders - Drug Targets Synthesis, Characterization and Antibacterial Evaluation of some New 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines as Potential Antibacterial Agents
Letters in Drug Design & Discovery Cannabinoids and Neuropathic Pain
Mini-Reviews in Medicinal Chemistry Intrinsic Disorder in Male Sex Determination: Disorderedness of Proteins from the Sry Transcriptional Network
Current Protein & Peptide Science Interactions between Antidepressants and Warfarin: A Review
Current Psychiatry Research and Reviews Levosimendan Prevents Memory Impairment Induced by Diabetes in Rats: Role of Oxidative Stress
Current Alzheimer Research Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials
Medicinal Chemistry Galanthamine, a Natural Product for the Treatment of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued)